Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
ProceedingsPoster Presentations
Open Access

Mesenchymal Stromal Cells in Systemic Sclerosis Have a Profibrotic and Senescent Transcriptomic Profile

Marianela Brizio, Benoit Brilland, Maximilien Lora, Mathieu Mancini, Marie Hudson, David Langlais and Ines Colmegna
The Journal of Rheumatology August 2026, 53 (Suppl 1) 153; DOI: https://doi.org/10.3899/jrheum.2026-0447.208
Marianela Brizio
McGill University, Montreal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benoit Brilland
Angers University Hospital, Angers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maximilien Lora
Research Institute MUHC, Montreal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathieu Mancini
McGill University, Montreal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie Hudson
McGill University, Jewish General Hospital, Lady Davis Institute for Medical Research, Montreal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Langlais
McGill University, Montreal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ines Colmegna
The Research Institute of the MUHC, Montreal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Previous
Loading

Abstract

Objectives Mesenchymal stromal cells (MSCs) are non-hematopoietic multipotent cells with immunomodulatory, proangiogenic, and antifibrotic properties.[1] The 3 pathogenic axes in systemic sclerosis (SSc) are autoimmunity, vasculopathy, and fibrosis.[2] Considering that donor characteristics impact MSCs’ functional properties,[3] we hypothesized that adipose-derived MSCs in SSc are dysfunctional. We aimed to characterize MSC’s phenotype from healthy donors and SSc patients.

Methods MSCs were isolated from adipose tissue contained in 2 4 mm forearm punch biopsies performed on 8 SSc patients and 8 age- and sex-matched healthy controls (Ctrl). MSCs were characterized according to the International Society for Cell and Gene Therapy (ISCT) minimal criteria. Bulk RNA sequencing was done and differentially expressed genes (DEGs) were defined as a fold change >2 or <−2, and a Benjamini-Hochberg adjusted p-value <0.05. Unsupervised hierarchical clustering and gene set enrichment analysis (GSEA) were conducted to identify enriched biological processes and signaling pathways.

Results SSc and Ctrl MSCs met ISCT criteria (ie, adhered to plastic, differentiated into 3 lineages, and exhibited specific surface markers). Compared to Ctrl, SSc MSCs had 151 upregulated and 16 downregulated genes (Figure 1A). GSEA documented the enrichment of profibrotic and senescence pathways in SSc MSCs (Figure 1B-C) which depicted a myofibroblast-like phenotype, characterized by increased ACTA2 expression.

  • Download figure
  • Open in new tab
  • Download powerpoint

Conclusion SSc MSCs have a distinct transcriptomic profile with enrichment of profibrotic and senescence pathways which may contribute to disease pathogenesis. Future studies will explore the effects of MSC modulation on mitigating SSc severity.

References [1.] Farge D. Autoimmun Rev 2021;20:102755. [2.] Denton CP. Lancet 2017;390:1685-99. [3.] Kizilay Mancini O. Stem Cell Res Ther 2015;8:140.

  • Copyright © 2026 by the Journal of Rheumatology

This is an Open Access article, which permits use, distribution, and reproduction, without modification, provided the original article is correctly cited and is not used for commercial purposes.

Previous
Back to top

In this issue

The Journal of Rheumatology: 53 (Suppl 1)
The Journal of Rheumatology
Vol. 53, Issue Suppl 1
1 Aug 2026
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
  • Front Matter (PDF)
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Mesenchymal Stromal Cells in Systemic Sclerosis Have a Profibrotic and Senescent Transcriptomic Profile
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Mesenchymal Stromal Cells in Systemic Sclerosis Have a Profibrotic and Senescent Transcriptomic Profile
Marianela Brizio, Benoit Brilland, Maximilien Lora, Mathieu Mancini, Marie Hudson, David Langlais, Ines Colmegna
The Journal of Rheumatology Aug 2026, 53 (Suppl 1) 153; DOI: 10.3899/jrheum.2026-0447.208

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Mesenchymal Stromal Cells in Systemic Sclerosis Have a Profibrotic and Senescent Transcriptomic Profile
Marianela Brizio, Benoit Brilland, Maximilien Lora, Mathieu Mancini, Marie Hudson, David Langlais, Ines Colmegna
The Journal of Rheumatology Aug 2026, 53 (Suppl 1) 153; DOI: 10.3899/jrheum.2026-0447.208
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Lenalidomide-Induced Large Vessel Vasculitis and Pachymeningitis Complicating Treatment of Follicular Lymphoma: A Case Report
  • Idiopathic AA Renal Amyloidosis Treated with Tocilizumab — A Case Report
  • Implementation of the Appointments by Choice Model for Rheumatoid Arthritis: A Patient-Initiated Follow-Up Pilot Study
Show more Poster Presentations

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire